🏛️ Verified NIH Record • Updated 2026-08-17

Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation (NCT07777744)

Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University Hospital, Basel, Switzerland

🩺 Plain-English Summary (8th-Grade Level)

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Who can join: Review the eligibility criteria below.

Location: Rush University Medical Center — Chicago, Illinois

Age range: 18 Years

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (25 Sites)

  • Rush University Medical Center — Chicago, Illinois
  • University of Michigan — Michigan Center, Michigan
  • Medical University of Graz — Graz,
  • Université Laval — Québec,
  • The First Affiliated Hospital of Nanjing Medical University — Nanjing,
  • University Hospital Center Sestre milosrdnice — Zagreb,
  • CHU Bordeaux — Bordeaux,
  • Centre Hospitalier Universitaire Trousseau — Chambray-lès-Tours,
  • University Hospital Poitier — Poitiers,
  • Clinique Pasteur Toulouse — Toulouse,
  • Zentralklinik Bad Bercka — Bad Berka,
  • Uniklinik Freiburg — Bad Krozingen,
  • Carl-Thiem-Klinikum — Cottbus,
  • Universitätsklinikum Münster — Münster,
  • University of Patras — Pátrai,
  • Sheba Medical Center — Ramat Gan,
  • Citta della Salute e della Scienza di Torino — Torino,
  • Mount Elisabeth Medical Centre — Singapore,
  • University Medical Center Ljubljana — Ljubljana,
  • Hospital Universitario Ramón y Cajal — Madrid,
  • University Hospital Basel — Basel,
  • Inselspital Bern — Bern,
  • Ankara City Hospital — Ankara,
  • Hacettepe University — Ankara,
  • Royal Papworth Hospital — Cambridge,

📞 Contact the Study Coordinator

Phone: 0041 61 265 52 14

Email: Michael.kuehne@usb.ch

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗